|
⚲
|
| Keyboard |
| Finney Kevin
✚
|
|
|---|---|
| CIK # | 0002053381 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002053381] | |
| 4 | [0002053381] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Finney Kevin | |
| NABI Biopharmaceuticals |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-08-15 | Buy | 50,000 | $0.37 | 18,500 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-08-15 | Buy | 50,000 | $0.35 | 17,500 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-07-30 | Buy | 25,874 | $0.38 | 9,832 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-07-28 | Buy | 20,000 | $0.40 | 8,000 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-07-25 | Buy | 20,000 | $0.39 | 7,800 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-07-17 | Buy | 794 | $0.38 | 302 |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2025-06-13 | Grant | 36,392 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-06-13 | Grant | 6,103 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-01-28 | Grant | 32,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2025-01-28 | Grant | 190,800 | $0.00 |